[india-drug] Response to Drug Promotion in India

["Dr.P.R.Pabrai" <pabrai@vsnl.com>]

Response to Drug Promotion in India
-------------------------------------


Dear Idrug participants,

I think it is a total failure of the regulatory authority. Who is 
bothered about the consumer or the poor patient? Why did it grant
permission to the Company to manufacture and market such a dubious
product? While the manufacturer would be keen to make money why should
the regulatory authority be abdicating its right to check unscrupulous
parties from behaving the way they do? So unless the regulatory
authority is pulled up effectively, we shall continue to have such
products on the market. We had a similar situation with Disprin Plus
sometime back. Some of the State Drug Controllers are behaving in the
most irresponsible manner. I think it is high time the Centre takes
over licencing of manufacture also. Let the Drugs & Cosmetics Act get
amended suitably.

DR P R PABRAI
C-568, Sarita Vihar
New Delhi 110 044
Tele: 9111-2694-0360
Mobile: 9810495330



________________________________________________________________________
Yahoo! India Insurance Special: Be informed on the best policies, services, tools and more. 
Go to: http://in.insurance.yahoo.com/licspecial/index.html

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org